Scientific work

Doç. Dr. Mustafa Çakan

158 publications. The source of the information is stated next to each publication.

Back to profile
  1. Defining Inactivity of Juvenile Spondyloarthropathies: Delphi Study Among Pediatric Rheumatology Academy ( PeRA ) From Türkiye

    International Journal of Rheumatic Diseases, 2026

    DOI 10.1111/1756-185x.70606 PMID 41821199 Source: OpenAlex

  2. How Well Do the New EULAR/ACR Classification Criteria Capture Pediatric Chronic Nonbacterial Osteomyelitis? A Multicenter Pediatric Cohort Study

    Journal of Pediatric Orthopaedics, 2026

    DOI 10.1097/bpo.0000000000003280 PMID 41988740 Source: OpenAlex

  3. Factors predicting the severity of gastrointestinal involvement in children with IgA vasculitis? A Turkish multicenter cohort study

    European Journal of Pediatrics, 2026

    DOI 10.1007/s00431-026-07162-4 PMID 42289526 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  4. Evaluating Consensus Treatment Plans for Chronic Nonbacterial Osteomyelitis Using Real-World Data

    Children, 2026

    DOI 10.3390/children13101410 PMID 42940729 Open-access full textSource: OpenAlex

  5. Comment on: How early is early for JIA? Insights from the infantile-onset juvenile idiopathic arthritis patients of the PERA research group cohort: reply

    Rheumatology, 2026

    DOI 10.1093/rheumatology/keaf683 PMID 41390971 Source: ORCID

  6. The effect of colchicine on micronutrients in children with newly diagnosed familial Mediterranean fever

    Jornal de Pediatria, 2026

    DOI 10.1016/j.jped.2026.101554 PMID 42114813 Open-access full textSource: ORCID

  7. Phenotype-genotype correlation and treatment outcomes in mevalonate kinase deficiency: A large Turkish cohort

    Seminars in Arthritis and Rheumatism, 2026

    DOI 10.1016/j.semarthrit.2026.152963 PMID 41833237 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  8. Comparable long-term outcomes with biosimilar and originator adalimumab in juvenile idiopathic arthritis: a multicenter cohort study

    Expert Opinion on Biological Therapy, 2026

    DOI 10.1080/14712598.2026.2723535 PMID 42644772 Source: ORCID

  9. Exploring nailfold videocapillaroscopy in children with psoriatic arthritis: are there any hidden vascular signatures?

    Modern Rheumatology, 2026

    DOI 10.1093/mr/roaf079 PMID 40879278 1 citation (Europe PMC) Open-access full textSource: ORCID

  10. Clinical Outcomes and Management Challenges of Pediatric Uveitis Associated with Systemic Rheumatic Diseases

    The Medical Bulletin of Haseki, 2026

    DOI 10.4274/haseki.galenos.2026.17363 Open-access full textSource: ORCID

  11. Cutaneous manifestations of autoinflammatory bone diseases: a retrospective multicenter study

    Clinical Rheumatology, 2026

    DOI 10.1007/s10067-025-07870-6 PMID 41372712 1 citation (Europe PMC) Open-access full textSource: ORCID

  12. Evaluation of 334 paediatric chronic non-bacterial osteomyelitis cases: A multicentre cohort study defining clusters

    Modern Rheumatology, 2026

    DOI 10.1093/mr/roag019 PMID 41761772 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  13. A specific component of familial Mediterranean fever: Menstrual attacks only

    Zeynep Kamil Medical Journal, 2026

    DOI 10.14744/zkmj.2025.88972 Source: OpenAlex

  14. Outcome measures for cutaneous and musculoskeletal involvement in juvenile systemic sclerosis: a scoping literature review

    Clinical and Experimental Rheumatology, 2026

    DOI 10.55563/clinexprheumatol/00khha PMID 42635162 Open-access full textSource: OpenAlex

  15. Domains and outcome measures for the assessment of cardiac involvement in juvenile systemic sclerosis: a scoping literature review

    Clinical and Experimental Rheumatology, 2026

    DOI 10.55563/clinexprheumatol/q8g25b PMID 42635163 Open-access full textSource: OpenAlex

  16. Domains and outcome measures for the assessment of digital vasculopathy and Raynaud's phenomenon in adult and juvenile systemic sclerosis: a scoping literature review

    Clinical and Experimental Rheumatology, 2026

    DOI 10.55563/clinexprheumatol/76mozn PMID 42635152 Open-access full textSource: OpenAlex

  17. The liver dilemma in pediatric familial Mediterranean fever: colchicine toxicity or inflammatory activity? A cohort study of 179 patients

    Pediatric Rheumatology, 2026

    DOI 10.1186/s12969-026-01280-x Open-access full textSource: OpenAlex

  18. Cyclophosphamide treatment with a comparison in both pediatric rheumatology and pediatric nephrology practices

    Pediatric Rheumatology, 2025

    DOI 10.1186/s12969-025-01080-9 PMID 40069880 3 citations (Europe PMC) Open-access full textSource: OpenAlex

  19. Predicting homozygous M694V genotype in paediatric FMF: multicentre analysis and scoring system proposal

    Rheumatology, 2025

    DOI 10.1093/rheumatology/keaf221 PMID 40257440 11 citations (Europe PMC) Open-access full textSource: OpenAlex

  20. Demographic and Clinical Characteristics of Pediatric Uveitis Cases from a Referral Center in Turkey

    Ocular Immunology and Inflammation, 2025

    DOI 10.1080/09273948.2025.2546954 PMID 40792602 1 citation (Europe PMC) Source: OpenAlex

  21. Longitudinal assessment of disease burden in juvenile systemic lupus erythematosus: A multicenter study of activity and damage scores

    Lupus, 2025

    DOI 10.1177/09612033251386091 PMID 41021284 1 citation (Europe PMC) Source: OpenAlex

  22. Three-year follow up of canakinumab dose extension in children with colchicine resistant fasmilial Mediterranean fever: PeRA-RG Experience

    Rheumatology, 2025

    DOI 10.1093/rheumatology/keaf403 PMID 40748721 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  23. ÇOCUKLARDA PFAPA HASTALIĞINDA TONSILLEKTOMI GEREKLILIĞINI ÖNGÖREBILIR MIYIZ?

    Kocaeli Üniversitesi - AVESİS, 2025

    Open-access full textSource: OpenAlex

  24. Is it possible to predict the need for tonsillectomy in children with PFAPA?

    Kocaeli Üniversitesi - AVESİS, 2025

    Source: OpenAlex

  25. KRONİK BAKTERİYEL OLMAYAN OSTEOMYELİT İÇİN KONSENSÜS TEDAVİ PLANLARININ GERÇEK DÜNYA VERİLERİ KULLANILARAK DEĞERLENDİRİLMESİ

    Kocaeli Üniversitesi - AVESİS, 2025

    Source: OpenAlex

  26. How early is early for JIA? Insights from the infantile-onset juvenile idiopathic arthritis patients of the PERA research group cohort

    Rheumatology, 2025

    DOI 10.1093/rheumatology/keaf440 PMID 40811013 3 citations (Europe PMC) Source: ORCID

  27. Clinical and laboratory predictors of biologic therapy use in enthesitis-related arthritis and Juvenile psoriatic arthritis

    Kocaeli Üniversitesi - AVESİS, 2025

    Source: OpenAlex

  28. Clinical use of intravenous immunoglobulin in juvenile dermatomyositis: indications, treatment course, and clinical outcomes

    Expert opinion on biological therapy, 2025

    DOI 10.1080/14712598.2025.2604058 PMID 41381187 Source: Europe PMC

  29. POS0830 NAILFOLD VIDEOCAPILLAROSCOPY IN CHILDREN WITH PSORIATIC ARTHRITIS: ARE THERE ANY HIDDEN VASCULAR SIGNATURES

    Annals of the Rheumatic Diseases, 2025

    DOI 10.1016/j.ard.2025.06.186 Open-access full textSource: OpenAlex

  30. Evaluation of disease activity and damage index in patients diagnosed with juvenile systemic lupus erythematosus

    Kocaeli Üniversitesi - AVESİS, 2025

    Source: OpenAlex

  31. Intravenous immunoglobulin therapy in juvenile dermatomyositis: a multicenter retrospective evaluation of clinical practice

    Kocaeli Üniversitesi - AVESİS, 2025

    Source: OpenAlex

  32. Developing consensus outcome measures in juvenile systemic sclerosis: a global survey of pediatric rheumatologists and literature review

    Pediatric Rheumatology, 2025

    DOI 10.1186/s12969-025-01100-8 PMID 40312718 11 citations (OpenAlex) Open-access full textSource: OpenAlex

  33. Clusters in paediatric Behçet’s disease: a multicentre international study

    RMD Open, 2025

    DOI 10.1136/rmdopen-2024-005335 PMID 40617583 11 citations (OpenAlex) Open-access full textSource: OpenAlex

  34. Syndrome of undifferentiated recurrent fever (SURF): a multicenter real-world experience from Türkiye

    Clinical Rheumatology, 2025

    DOI 10.1007/s10067-025-07682-8 PMID 40968336 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  35. Hepatitis B vaccine and juvenile idiopathic arthritis: comparison of the seropositivity rates with healthy children at the time of diagnosis and booster dose response under treatment

    Clinical Rheumatology, 2025

    DOI 10.1007/s10067-025-07313-2 PMID 39808236 2 citations (OpenAlex) Source: OpenAlex

  36. Measles-mumps-rubella booster vaccination in juvenile idiopathic arthritis patients while receiving biological agents

    Clinical Rheumatology, 2025

    DOI 10.1007/s10067-025-07318-x PMID 39798065 Source: OpenAlex

  37. Exploring factors for predicting colchicine responsiveness in children with PFAPA

    European Journal of Pediatrics, 2024

    DOI 10.1007/s00431-024-05703-3 PMID 39085658 8 citations (Europe PMC) Open-access full textSource: OpenAlex

  38. Towards a standardized program of transitional care for adolescents with juvenile idiopathic arthritis for Turkey: a national survey study

    Pediatric Rheumatology, 2024

    DOI 10.1186/s12969-023-00943-3 PMID 38167070 8 citations (Europe PMC) Open-access full textSource: OpenAlex

  39. Evaluation of pediatric rheumatologists’ approach to rituximab use: a questionnaire study

    European Journal of Pediatrics, 2024

    DOI 10.1007/s00431-024-05654-9 PMID 38926187 5 citations (Europe PMC) Source: OpenAlex

  40. The journey of MEFV heterozygous children: with or without colchicine

    European Journal of Pediatrics, 2024

    DOI 10.1007/s00431-024-05887-8 PMID 39581919 4 citations (Europe PMC) Source: OpenAlex

  41. Consensus on transition care for juvenile idiopathic arthritis: a Delphi study with youth, caregivers, and health professionals

    Pediatric Rheumatology, 2024

    DOI 10.1186/s12969-024-01047-2 PMID 39695685 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  42. Çocuklarda PFAPA Hasatlığında Kolşisin Yanıtını Öngörebilir Miyiz.

    Kocaeli Üniversitesi - AVESİS, 2024

    Source: OpenAlex

  43. Evaluation of childhood malignancies presenting with musculoskeletal manifestations from two different divisions: a multicenter study

    The Turkish Journal of Pediatrics, 2024

    DOI 10.24953/turkjped.2023.446 PMID 38523382 3 citations (Europe PMC) Open-access full textSource: ORCID

  44. RHEUMATOID FACTOR: WHAT GOOD FOR PEDIATRIC RHEUMATOLOGY?

    Rheumatology Quarterly, 2024

    DOI 10.4274/qrheumatol.galenos.2024.18480 Open-access full textSource: ORCID

  45. Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: A multicenter study

    Joint Bone Spine, 2023

    DOI 10.1016/j.jbspin.2023.105559 PMID 36858168 22 citations (Europe PMC) Open-access full textSource: OpenAlex

  46. Inflammatory comorbidities ın the largest pediatric Familial Mediterranean fever cohort: a multicenter retrospective study of Pediatric Rheumatology Academy (PeRA)-Research Group (RG)

    Clinical Rheumatology, 2023

    DOI 10.1007/s10067-023-06802-6 PMID 37926798 9 citations (Europe PMC) Source: OpenAlex

  47. How common is remission in rheumatoid factor-positive juvenile idiopathic arthritis patients? The multicenter Pediatric Rheumatology Academy (PeRA) research group experience

    Pediatric Rheumatology, 2023

    DOI 10.1186/s12969-023-00860-5 PMID 37475055 6 citations (Europe PMC) Open-access full textSource: OpenAlex

  48. The assessment of autoinflammatory disease classification criteria (Eurofever/PRINTO) in a real-life cohort

    Clinical Rheumatology, 2023

    DOI 10.1007/s10067-023-06557-0 PMID 36826737 10 citations (Europe PMC) Source: OpenAlex

  49. The safety of canakinumab in systemic juvenile idiopathic arthritis and autoinflammatory diseases in pediatric patients: a multicenter study

    Expert Opinion on Biological Therapy, 2023

    DOI 10.1080/14712598.2023.2282133 PMID 37970654 7 citations (Europe PMC) Source: OpenAlex

  50. PREDICT-crFMF score: A novel model for predicting colchicine resistance in children with familial Mediterranean fever

    Modern Rheumatology, 2023

    DOI 10.1093/mr/road008 PMID 36680425 1 citation (Europe PMC) Source: OpenAlex